OC
STAB

Oppenheimer & Co’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Oppenheimer & Co’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,275
Closed -$17K – 1497
2014
Q1 		$17K Sell
1,275
-700
-35% -$11.4K ﹤0.01% 1392
2013
Q4 		$46K Sell
1,975
-382
-16% -$10.4K ﹤0.01% 1351
2013
Q3 		$74K Sell
2,357
-74
-3% -$2.45K ﹤0.01% 1262
2013
Q2 		$77K Buy
+2,431
New +$83.7K ﹤0.01% 1211

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AW
ACG Wealth Atlanta, Georgia $437M AUM 11.28% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Oppenheimer & Co's STAB Position: Q2 2014 in Review

Oppenheimer & Co sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q2 2014, closing a stake of 1,275 shares — an estimated $17K sold.

Oppenheimer & Co first reported a position in STAB in Q2 2013 and held it in 4 quarters. The position peaked at $77K in Q2 2013. 31 funds tracked by Wall St. Rank hold STAB as of Q2 2014.

  • Oppenheimer & Co reported no remaining Statera Biopharma, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • Oppenheimer & Co sold 1,275 Statera Biopharma, Inc. Common Stock shares in Q2 2014, an estimated $17K.
  • Oppenheimer & Co first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 4 quarters.
  • Oppenheimer & Co's Statera Biopharma, Inc. Common Stock position peaked at $77K in Q2 2013.
  • 31 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q2 2014.

Based on Oppenheimer & Co's 13F filing for Q2 2014, filed 14 Aug 2014.